Skip to main content

Advertisement

Table 1 Patient demographics of ITT population

From: Comparison of rosuvastatin and atorvastatin for lipid lowering in patients with type 2 diabetes mellitus: results from the URANUS study

  Rosuvastatin (n = 232) Atorvastatin (n = 233)
Gender, male/female (%) 128/104 (55.2/44.8) 136/97 (58.4/41.6)
Race, white (%) 229 (98.7) 229 (98.3)
Mean age, years (SD) 63.5 (8.8) 65.0 (8.6)
Mean weight, kg (SD) 84.8 (14.3) 82.5 (13.5)
Mean BMI, kg/m2 (SD) 29.0 (3.6) 28.4 (3.6)
Mean baseline LDL-C, mmol/L (SD) 4.6 (0.85) 4.6 (0.82)a
Mean baseline HDL-C, mmol/L (SD) 1.2 (0.27) 1.2 (0.27)a
Mean baseline TG, mmol/L (SD) 2.0 (1.0) 2.0 (0.93)a
  1. ITT: Intention to treat, SD: Standard deviation, BMI: Body mass index, LDL-C: Low-density lipoprotein cholesterol, HDL-C: High-density lipoprotein cholesterol, TG: Triglycerides
  2. an = 232